Here are updates on two of your buys: Corteva & Garmin

Article Excerpt

Long-time readers know that we aim to keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to bolster investor gains. Here are two buys that stand out this month: CORTEVA INC., $57.13, is a buy. The company (New York symbol CTVA; TSINetwork Rating: Extra Risk) (www.corteva.com; Shares outstanding: 697.0 million; Market cap: $39.8 billion; Dividend yield: 1.1%) is a leading developer of new seeds and crop chemicals including herbicides and insecticides for the agriculture industry. In the quarter ended March 31, 2024, revenue fell 8.0%, to $4.49 billion from $4.88 billion a year earlier. Strong performance in the company’s North American seed business offset weakness in its crop protection unit. Excluding one-time items, Corteva made $0.89 in the latest quarter. That’s down 23.3% from $1.16. The decline came from the lower crop protection sales, as well as higher input costs. Corteva’s outlook remains positive, along with its industry fundamentals. Those bright prospects are supported by rising…